Tag: Lotus Edge
Novel repositionable TAVI valve has acceptable early clinical outcomes
A new study indicates that the Meridian transcatheter aortic valve implantation (TAVI) valve (HL...
Lotus Edge becomes third TAVI device on US market
Boston Scientific has received US FDA approval for its Lotus Edge transcatheter aortic valve imp...
Boston Scientific pushes back plans for commercialisation of Lotus Edge TAVI device
Boston Scientific has announced a delay to the previously communicated timelines for the commerc...
PCR LV 2017: Refining implantation technique and device iterations may improve pacemaker rate seen with Lotus
New data from REPRISE III indicate that keeping the bottom of the frame at annular level while i...
